Meng-Lan Wang

985 total citations
42 papers, 720 citations indexed

About

Meng-Lan Wang is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Meng-Lan Wang has authored 42 papers receiving a total of 720 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Hepatology, 26 papers in Epidemiology and 8 papers in Surgery. Recurrent topics in Meng-Lan Wang's work include Liver Disease Diagnosis and Treatment (21 papers), Hepatitis B Virus Studies (21 papers) and Hepatitis C virus research (17 papers). Meng-Lan Wang is often cited by papers focused on Liver Disease Diagnosis and Treatment (21 papers), Hepatitis B Virus Studies (21 papers) and Hepatitis C virus research (17 papers). Meng-Lan Wang collaborates with scholars based in China, Germany and United States. Meng-Lan Wang's co-authors include En‐Qiang Chen, Ya-Chao Tao, Hong Tang, Hong Tang, Dongbo Wu, Chuanmin Tao, Baskaran Thyagarajan, Lingyao Du, Lingyun Zhou and Yonghong Wang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Frontiers in Immunology.

In The Last Decade

Meng-Lan Wang

40 papers receiving 715 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Meng-Lan Wang 363 333 152 114 90 42 720
Kazunori Noguchi 265 0.7× 151 0.5× 152 1.0× 98 0.9× 78 0.9× 30 599
Qiang Xia 251 0.7× 222 0.7× 165 1.1× 256 2.2× 73 0.8× 61 766
Qiaoxuan Wang 162 0.4× 91 0.3× 212 1.4× 86 0.8× 79 0.9× 56 650
Stephen N. Greenhalgh 130 0.4× 124 0.4× 116 0.8× 85 0.7× 34 0.4× 18 387
Jingwen Zou 173 0.5× 78 0.2× 87 0.6× 105 0.9× 65 0.7× 48 453
Yoon Ok Jang 333 0.9× 241 0.7× 262 1.7× 246 2.2× 100 1.1× 28 768
Ren Lang 148 0.4× 89 0.3× 355 2.3× 165 1.4× 87 1.0× 54 701
Andreea Cătană 233 0.6× 119 0.4× 212 1.4× 331 2.9× 24 0.3× 41 673
Maryam Honardoost 172 0.5× 93 0.3× 251 1.7× 243 2.1× 35 0.4× 41 758

Countries citing papers authored by Meng-Lan Wang

Since Specialization
Citations

This map shows the geographic impact of Meng-Lan Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meng-Lan Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meng-Lan Wang more than expected).

Fields of papers citing papers by Meng-Lan Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meng-Lan Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meng-Lan Wang. The network helps show where Meng-Lan Wang may publish in the future.

Co-authorship network of co-authors of Meng-Lan Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Meng-Lan Wang. A scholar is included among the top collaborators of Meng-Lan Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meng-Lan Wang. Meng-Lan Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Yonghong, Bei Wu, Ya-Chao Tao, et al.. (2025). Therapeutic effect of hUC-MSCs from different transplantation routes on acute liver failure in rats. Frontiers in Medicine. 12. 1525719–1525719.
2.
Li, Lanqing, Jing Zhou, Yujing Li, et al.. (2023). Effectiveness and safety of tenofovir amibufenamide and its comparison with tenofovir alafenamide in patients with chronic hepatitis B: results from a retrospective real-world study. Frontiers in Pharmacology. 14. 1165990–1165990. 9 indexed citations
3.
Wang, Yonghong, Meng-Lan Wang, Ya-Chao Tao, et al.. (2023). The high level of IL-1β in the serum of ACLF patients induces increased IL-8 expression in hUC-MSCs and reduces the efficacy of hUC-MSCs in liver failure. Stem Cell Research & Therapy. 14(1). 231–231. 5 indexed citations
4.
Zhou, Jing, Yujing Li, Meng-Lan Wang, et al.. (2023). Improved bone and renal safety in younger tenofovir disoproxil fumarate experienced chronic hepatitis B patients after switching to tenofovir alafenamide or entecavir. Annals of Hepatology. 28(5). 101119–101119. 6 indexed citations
5.
Tao, Ya-Chao, Yonghong Wang, Meng-Lan Wang, et al.. (2022). Upregulation of microRNA-125b-5p alleviates acute liver failure by regulating the Keap1/Nrf2/HO-1 pathway. Frontiers in Immunology. 13. 988668–988668. 11 indexed citations
6.
7.
Wang, Yonghong, Ya-Chao Tao, Dongbo Wu, et al.. (2021). Cell heterogeneity, rather than the cell storage solution, affects the behavior of mesenchymal stem cells in vitro and in vivo. Stem Cell Research & Therapy. 12(1). 391–391. 25 indexed citations
8.
Lv, Duoduo, Youjuan Wang, Meng-Lan Wang, et al.. (2021). Effect of silibinin capsules combined with lifestyle modification on hepatic steatosis in patients with chronic hepatitis B. Scientific Reports. 11(1). 655–655. 17 indexed citations
9.
Wang, Meng-Lan, Xue‐Lian Li, Jing Zhou, et al.. (2021). Retrospective Analysis of the Clinical Efficacy of N-Acetylcysteine in the Treatment of Hepatitis B Virus Related Acute-on-Chronic Liver Failure. Frontiers in Medicine. 8. 724224–724224. 8 indexed citations
10.
Zhou, Jing, Meng-Lan Wang, Ya-Chao Tao, et al.. (2021). Antiviral Therapy for Chronic HBV Infection With Persistently Normal Alanine Aminotransferase: Controversy and Consensus. Frontiers in Medicine. 8. 717125–717125. 4 indexed citations
11.
Tao, Ya-Chao, Meng-Lan Wang, Dongbo Wu, et al.. (2019). Apolipoprotein A5 alleviates LPS/d-GalN-induced fulminant liver failure in mice by inhibiting TLR4-mediated NF-κB pathway. Journal of Translational Medicine. 17(1). 151–151. 20 indexed citations
12.
Lv, Duoduo, Meng-Lan Wang, En‐Qiang Chen, et al.. (2018). A retrospective study of the efficacy of sofosbuvir plus NS5A inhibitors for patients with hepatitis C virus genotype-2 chronic infection. European Journal of Gastroenterology & Hepatology. 31(3). 382–388. 3 indexed citations
13.
Yang, Zhu L., et al.. (2018). Molecular characterization of a new gammapartitivirus isolated from the citrus-pathogenic fungus Penicillium digitatum. Archives of Virology. 163(11). 3185–3189. 6 indexed citations
14.
15.
Tao, Ya-Chao, Meng-Lan Wang, Ming Wang, et al.. (2018). Quantification of circulating miR-125b-5p predicts survival in chronic hepatitis B patients with acute-on-chronic liver failure. Digestive and Liver Disease. 51(3). 412–418. 15 indexed citations
16.
Chen, En‐Qiang, Meng-Lan Wang, Dongmei Zhang, et al.. (2017). Plasma Apolipoprotein A-V Predicts Long-term Survival in Chronic Hepatitis B Patients with Acute-on-Chronic Liver Failure. Scientific Reports. 7(1). 45576–45576. 7 indexed citations
17.
Chen, En‐Qiang, Shu Feng, Meng-Lan Wang, et al.. (2017). Serum hepatitis B core-related antigen is a satisfactory surrogate marker of intrahepatic covalently closed circular DNA in chronic hepatitis B. Scientific Reports. 7(1). 173–173. 75 indexed citations
18.
Chen, Jing, Meng-Lan Wang, Qin Long, Lang Bai, & Hong Tang. (2017). High value of controlled attenuation parameter predicts a poor antiviral response in patients with chronic hepatits B. Hepatobiliary & pancreatic diseases international. 16(4). 370–374. 14 indexed citations
19.
Wang, Meng-Lan, Qiaoling Zhou, En‐Qiang Chen, et al.. (2016). Low Ratio of Treg to Th17 Cells After 36 Weeks of Telbivudine Therapy Predict HBeAg Seroconversion. Viral Immunology. 29(6). 332–342. 5 indexed citations
20.
Wang, Meng-Lan & Hong Tang. (2016). Nucleos(t)ide analogues causes HBV S gene mutations and carcinogenesis. Hepatobiliary & pancreatic diseases international. 15(6). 579–586. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kazunori Noguchi Breakdown of academic impact, for papers by Qiang Xia Breakdown of academic impact, for papers by Qiaoxuan Wang Breakdown of academic impact, for papers by Stephen N. Greenhalgh Breakdown of academic impact, for papers by Jingwen Zou Breakdown of academic impact, for papers by Yoon Ok Jang Breakdown of academic impact, for papers by Ren Lang Breakdown of academic impact, for papers by Andreea Cătană Breakdown of academic impact, for papers by Maryam Honardoost
Rankless by CCL
2026